Intra Cellular Therapies reported $121.03M in Cash and Equivalent for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Acadia Pharmaceuticals ACAD:US $ 266.96M 37.53M
Adamas Pharmaceuticals ADMS:US 88.8M 36.03M
ALKERMES ALKS:US $ 258.34M 53.31M
Aptinyx Inc APTX:US $ 129.23M 17.58M
Arena Pharmaceuticals ARNA:US $ 514.18M 81.2M
Biocryst Pharmaceuticals BCRX:US $ 218.43M 8.47M
Biogen BIIB:US $ 1541.8M 200.2M
Bristol Myers Squibb BMY:US $ 11024M 42M
Cytokinetics CYTK:US $ 37.15M 7.44M
Esperion Therapeutics ESPR:US $ 219.19M 1.25M
Gilead Sciences GILD:US $ 7361M 3296M
Gw Pharmaceuticals GWPH:US $ 458.1M 28.65M
Halozyme Therapeutics HALO:US $ 446.97M 52.48M
Intra Cellular Therapies ITCI:US $ 121.03M 8.95M
Marinus Pharmaceuticals MRNS:US $ 112.49M 10.98M
Minerva Neurosciences NERV:US $ 74.22M 5.92M
Nektar Therapeutics NKTR:US $ 152.34M 2.18M
Neurocrine Biosciences NBIX:US $ 368M 15.4M
Novartis NVS:US $ 5117M 1316M
Prothena PRTA:US $ 399.83M 56.84M
Redhill Biopharma RDHL:US $ 51.82M 24.16M
Supernus Pharmaceuticals SUPN:US $ 223.77M 31.87M
United Therapeutics UTHR:US $ 942.2M 109.9M
Vanda Pharmaceuticals VNDA:US $ 57.24M 14.89M
Zogenix ZGNX:US $ 77.33M 38.36M